Perez Rosal, Sergio R.
La Torre, Joseph T.
Birnkammer, Susanne
Chernoloz, Olga
Williams, Monnica T.
Faber, Sonya C. https://orcid.org/0000-0003-1122-4109
Article History
Received: 25 May 2024
Accepted: 4 October 2024
First Online: 24 October 2024
Declarations
:
: Author Sonya Faber is employed by Angelini Pharma and is a partner in the company Bioville GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The other authors declare no conflicts of interest.This paper contains no clinical trial and no need for ethics consent.